Bangladesh drug maker Beximco launches world's first generic of Pfizer's COVID antiviral

Pfizer's novel antiviral pill showed almost 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent data from Pfizer suggests the drug retains its effectiveness against the fast-spreading Omicron variant of the coronavirus.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news